Scalpel Weekly News

Week of: December 10, 2018

IN THE NEWS


More Contaminated Blood Pressure Drugs Recalled

On November 27, 2018, Teva Pharmaceuticals initiated a nationwide recall of all lots of Amlodipine/Valsartan combination tablets and Amlodipine/Valsartan/Hydrochlorothiazide combination tablets due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India. The impurity found in Mylan’s valsartan API is known as N-nitroso-diethylamine (NDEA), which has been classified as a probable human carcinogen. This chemical is typically found in very small amounts in certain foods, drinking water, air pollution, and certain industrial processes. Click title to continue reading...


 
MEDICAL ALERTS


First Test for Newborn Herpes Virus, Cytomegalovirus

On November 30, 2018, the FDA granted Meridian Bioscience, Inc., approval to market the Alethia CMV Assay Test System, a new diagnostic test to aid in detecting a type of herpes virus called cytomegalovirus (CMV) in newborns less than 21 days old. Click title to continue reading...



Acute Myeloid Leukemia Treatment

On November 28, 2018, the FDA granted Astellas Pharma approval to market Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. The FDA also approved an expanded indication for a companion diagnostic test, to include use with Xospata. The LeukoStrat CDx FLT3 Mutation Assay, developed by Invivoscribe Technologies, Inc., is used to detect the FLT3 mutation in patients with AML. Click title to continue reading...



Dangerous Eastern Asia Tick Spreading in U.S.

On November 29, 2018, the CDC published a report that found, during 2017 and 2018, Haemaphysalis longicornis, a tick that is an important vector of human disease agents has been detected in nine states. The presence of H. longicornis in the United States represents a new and emerging disease threat. Click title to continue reading...


  CASE ALERTS


Hospital Liable for Nurses’ Actions during Delivery; Infant Death

A patient presented to the hospital to give birth. The patient’s obstetrician ordered Pitocin to be administered to the patient during labor and delivery. Hospital employees administered Pitocin, a synthetic form of oxytocin, used to induce labor by making the uterus contract more forcefully causing stronger and longer contractions. The obstetrician used forceps during the delivery. The infant died shortly after birth. Click title to continue reading...



Illinois Health Services Plan Corporation Immune from Suit

A health services plan corporation was organized under the Illinois Voluntary Health Services Plan Act for the purpose of establishing and operating a voluntary health services plan and providing other medically related services. While under the care of the health services plan corporation’s physicians, nurses, and technicians, a patient died following a lymph node biopsy. Click title to continue reading...



Medicaid Long-Term Care Benefits Delayed Due To Special Needs Trust

A disabled couple resided in a nursing home. One partner in the couple had undergone two kidney transplants; had lymphedema, which caused swelling and made the left arm unusable; and required a number of medications daily. The other partner in the couple had suffered a stroke resulting in left side paralysis. Click title to continue reading...


FEATURE


Intake Checklist: Defendant in Surgical Burn Malpractice Action

As a special feature for our Premium subscribers, we have included this checklist to be used by counsel for an initial interview with a client who is a named defendant in a medical malpractice action involving surgical burns. In this illustrative situation, a man underwent high-current radiofrequency ablation to treat a tumor in the man’s liver. During the procedure, the man suffered third degree burns at the site of the grounding pad. The man sued the surgeon and the hospital for malpractice. Party identifying information has been redacted to protect privacy. Click title to continue reading...